Sales Manager

Pulmonary Hypertension Association announces new officers, board members. Pulmonary Hypertension Association Jul 29, 2026, 08:58 ET The new officers and board members bring leadership and expertise to advance PHA's mission. WASHINGTON, July 29, 2026 /PRNewswire-PRWeb/ - The Pulmonary Hypertension Association Board of Trustees began its new term July 1 with new officers and five new members. The new officers, who will serve two-year terms, are: * Chair: Mitchell Koppelman * Chair-elect: Diane Ramirez * Treasurer: Mike Lentz * Secretary: Nicole Creech * Immediate Past Chair: Traci Stewart Mitch Koppelman, PhD, is a retired vice president of strategic planning for Minerals Technologies and principal consultant for Mineral Solutions and Strategy, where he provides consulting and advisory services to multinational clients. He and his wife Debbie, who has pulmonary arterial hypertension, lost two daughters to pulmonary arterial hypertension. Koppelman is involved in local government and planning in Sanibel, Florida, and Seaside Park, New Jersey. Diane Ramirez, of Lexington, North Carolina, has served on the PHA board for 14 years. In September 2023, she underwent heart and lung transplant after living with PH for 36 years. Her primary motivation to help PHA with its mission comes from losing a brother and two sisters to PAH. She wants to help as many patients as possible. She has been involved with PHA advocacy and awareness since 2006. Mike Lentz, of Louisville, Kentucky, lost his wife Maureen to PH in 2016. He is managing director of the Jacksonville market for Nelson Worldwide, which specializes in the design of large-scale, mixed-use real estate developments throughout the United States. He has a long history of fundraising and supporting PH-related causes and served on PHA's finance and development committees. Nicole Creech, of Lexington, Kentucky, joined PHA in 2016 and became a volunteer to help find a cure. She also wanted to be empowered by hope and share that hope with others. She formerly chaired the Finance Committee and sits on several committees to provide a patient perspective. In her spare time, Creech serves her community as an end-of-life doula. She's also a court-appointed child advocate and enjoys visiting assisted living facilities with her Morkie, Teddy. Traci Stewart, RN, MSN, of Columbus Junction, Iowa, is a PH nurse clinician at Iowa Health Care's Heart and Vascular Center. She coordinates care as patients transition from inpatient and outpatient settings. Stewart has over 20 years of clinical expertise in managing pulmonary hypertension and heart failure patients. Her focus is providing patient, nurse and community education. New board members Jessie Dunne, PharmD, BCPS, BCCP, FACC, is a clinical pharmacist for advanced heart failure and transplant at Oregon Health and Science University. Dan Grinnan, MD, is medical director of the PHA-accredited PH Care Center at VCU Medical Center in Richmond, Virginia. Marcie McGregor joined PHA in 2012 soon after she was diagnosed with PAH. She founded and leads a PHA support group in Augusta, Georgia. George Peoples, MD, FACS, of Horseshoe Bay, Texas, became a PHA volunteer five years ago after his daughter was diagnosed with PH. A retired Army colonel, he is the executive medical director of Avance Clinical's Oncology Center of Excellence. Jim White, MD, is the founding director of the pulmonary arterial hypertension program at the University of Rochester Medical Center, a PHA-accredited Comprehensive Care Center. About the Pulmonary Hypertension Association Headquartered in Washington, D.C., the Pulmonary Hypertension Association is the oldest and largest nonprofit patient association dedicated to the pulmonary hypertension community. Pulmonary hypertension is a rare, chronic and life-threatening lung condition for which no cure currently exists. PHA's mission is to extend and improve the lives of those affected by PH. To achieve this mission, PHA engages people with PH and their families, caregivers, health care providers and researchers worldwide who work together to advocate for the PH community, support patients, caregivers and families, offer up-to-date education and information on PH, improve quality patient care, and fund and promote research. For more information, visit PHAssociation.org and connect with PHA on Bluesky, Instagram, Facebook and LinkedIn. Media Contact Karen Smaalders, Pulmonary Hypertension Association, 1 240-485-0750, [email protected] SOURCE Pulmonary Hypertension Association

Minerals Technologies Inc. has published its 18th Sustainability Report, announcing it achieved all 12 environmental targets set in 2018 and established new 10-year goals through 2035. The New York-based specialty minerals company reduced Scope 1 emissions by 34% and Scope 2 emissions by 42% in absolute terms, exceeding its original targets. MTI also cut landfill waste by 44%, more than doubling its 20% reduction target, and decreased water withdrawal by 31%. In 2025, 67% of the company's new products had a sustainable profile. MTI achieved a record-low injury rate of 0.54, with 92% of sites operating injury-free. The company reported global sales of $2.1 billion in 2025 and employs 4,000 people across 34 countries.

Minerals Technologies Inc. has filed a plan of reorganisation in the Chapter 11 bankruptcy cases of its subsidiary BMI OldCo Inc. and affiliated debtors. The filing meets a court-imposed deadline whilst broader disputes remain pending before the US District Court for the Southern District of Texas. The plan proposes a $450 million trust fund to address current and future talc-related claims, with a channeling injunction protecting non-debtor affiliates. MTI maintains that BMI OldCo's talc products are safe and the lawsuits are meritless. The company will record a $290 million charge in Q2 2026 to increase reserves for estimated costs. MTI continues funding the debtors' administrative expenses whilst awaiting the district court's determination on whether BMI OldCo's talc contained asbestos.